Curis | CRIS - Cost Of Sales


Curis reported $314K in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.87B 271M Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
CSL USD 3.87B 2.08B Dec/2025
Curis USD 314K 9.96M Dec/2025
Eli Lilly USD 3.27B 309M Jun/2026
Exelixis USD 20.66M 704K Jun/2026
Gilead Sciences USD 1000M 445M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Incyte USD 104.96M 457K Jun/2026
Merck USD 3.14B 200M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Takeda JPY 517.6B 42.94B Jun/2026
TG Therapeutics USD 41.19M 7.68M Jun/2026
Verastem USD 3.05M 159K Mar/2026